Depletion of human NK and CD8 cells prior to in vitro H1N1 flu vaccine stimulation increases the number of gamma interferon-secreting cells compared to the initial undepleted population in an ELISPOT assay
- PMID: 11874857
- PMCID: PMC119957
- DOI: 10.1128/cdli.9.2.230-235.2002
Depletion of human NK and CD8 cells prior to in vitro H1N1 flu vaccine stimulation increases the number of gamma interferon-secreting cells compared to the initial undepleted population in an ELISPOT assay
Abstract
In order to study the respective roles of CD4, CD8, and CD56 (NK) cells in gamma interferon (IFN-gamma) production after in vitro stimulation with flu vaccine in a healthy adult human population, we depleted these cellular subtypes before stimulation with antigen (inactivated split vaccine, A/Texas H1N1, or A/Sydney H3N2). We observed that while CD4 cells were required for IFN-gamma secretion in both conditions in vitro, CD56 (NK) cells and, to a lesser extent, CD8 cells had a negative effect on such synthesis upon H1N1 stimulation, as judged by an increased number of spots compared to the initial undepleted population. This regulation of IFN-gamma secretion was associated with an increase in ICAM-1 expression, in particular on T and B cells. This study points out the importance of evaluating in vitro immune responses on a whole-cell population in addition to isolated subtypes if one needs to address potential cellular interactions occurring in vivo in some situations (H1N1 stimulation in the present case). Such cross-regulations occur even in vitro during the antigenic stimulation step.
Figures






Similar articles
-
Epitope specific T-cell responses against influenza A in a healthy population.Immunology. 2016 Feb;147(2):165-77. doi: 10.1111/imm.12548. Epub 2015 Dec 8. Immunology. 2016. PMID: 26489873 Free PMC article.
-
CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.Eur J Immunol. 2012 Jul;42(7):1755-66. doi: 10.1002/eji.201242393. Eur J Immunol. 2012. PMID: 22585549
-
Low expression of activation marker CD69 and chemokine receptors CCR5 and CXCR3 on memory T cells after 2009 H1N1 influenza A antigen stimulation in vitro following H1N1 vaccination of HIV-infected individuals.Hum Vaccin Immunother. 2015;11(9):2253-65. doi: 10.1080/21645515.2015.1051275. Epub 2015 Jun 19. Hum Vaccin Immunother. 2015. PMID: 26091502 Free PMC article.
-
Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients.Transpl Infect Dis. 2015 Jun;17(3):371-9. doi: 10.1111/tid.12382. Epub 2015 Jun 1. Transpl Infect Dis. 2015. PMID: 25817044
-
An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.BMC Immunol. 2017 Mar 7;18(1):14. doi: 10.1186/s12865-017-0195-y. BMC Immunol. 2017. PMID: 28270111 Free PMC article.
Cited by
-
Role of Baicalin in Anti-Influenza Virus A as a Potent Inducer of IFN-Gamma.Biomed Res Int. 2015;2015:263630. doi: 10.1155/2015/263630. Epub 2015 Dec 10. Biomed Res Int. 2015. PMID: 26783516 Free PMC article.
References
-
- Beck, M. A., and J. F. Sheridan. 1989. Regulation of lymphokine response during reinfection by influenza virus: production of a factor that inhibits lymphokine activity. J. Immunol. 142:3560-3567. - PubMed
-
- Carbone, E., G. Terrazzano, G. Ruggiero, D. Zanzi, A. Ottaiano, C. Manzo, K. Karre, and S. Zappacosta. 1999. Recognition of autologous dendritic cells by human NK cells. Eur. J. Immunol. 29:4022-4029. - PubMed
-
- Couch, R. B., and J. A. Kasel. 1983. Immunity to influenza in man. Annu. Rev. Microbiol. 37:529-549. - PubMed
-
- Cox, N. J., and K. Subbarao. 1999. Influenza. Lancet 354:1277-1282. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous